This study is testing a treatment called Fecal Microbiota Transplant (FMT) for people with Parkinson's disease. Researchers believe that an imbalance of gut bacteria might play a role in Parkinson's, and FMT could help improve symptoms and quality of life. The study is open to individuals aged 18 to 85 who have been diagnosed with Parkinson's disease. The main goal is to see how Parkinson's symptoms change after FMT, measured over about 6.5 months. The current status of this study is unclear, and it plans to enroll 10 participants.

Study design

This is an open-label study, meaning both you and the study team will know you are receiving the treatment. It plans to include 10 participants.

What's involved

You would have 11 in-person visits, including two for consent and assessment, one for colonoscopy instructions, one for the FMT procedure, and seven for post-FMT assessments. There will also be daily phone calls for one week after FMT, and weekly phone calls when there isn't a physical visit.

Compensation

Not stated in the trial record.

Follow-up

You will be followed for approximately 6.5 months after the treatment to assess Parkinson's disease symptoms.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.